Planatome, Medikana Team Up for Latin American Distribution Effort

Planatome is partnering with Medikana to advance its Central and South American footprint. Based on its success within Venezuela, the Dominican Republic, and Panama, this agreement extends Planatome’s scalpel blade technology across a surgically booming Latin American region.
 
“Our partnership with Medikana is a solid foothold in furthering our mission of improving the lives of others, particularly for patients at risk of adverse healing events such as keloid and hypertrophic scarring,” Planatome CEO Tim Tobin said. “Medikana’s network and expertise in the Latin American market lands squarely on this critical patient demographic and will be invaluable as we work to provide surgeons and their patients with extraordinary surgical outcomes.”
 
This distribution agreement reflects Planatome’s commitment to setting a new standard in patient care. 
 
“We are thrilled to partner with Planatome, a company that is setting new standards in surgical technology. This collaboration aligns perfectly with Medikana’s mission to enhance access to cutting-edge medical solutions across Latin America. Together, we are proud to bring Planatome’s low-trauma surgical blades to thousands of patients, supporting faster healing and better outcomes, advancing the quality of care throughout the region. This partnership is just the beginning of our shared journey to transform healthcare in LATAM,” Medikana CEO Corina Negron stated.
 
Medikana, an MIT-backed platform, specializes in streamlining and automating medical device commercialization inclusive to Central and South America. Its services include market opportunity analysis, strategic partner matchmaking, and navigating regulatory landscapes, ensuring that medical technologies reach the right markets efficiently. With a deep understanding of both the U.S. medtech industry and the Latin American healthcare systems, Medikana is positioned to help Planatome amplify its reach and influence in the Latin American market.
 
Founded in 2017, Planatome is a medical device technology company based in Phoenix, Ariz. The company has developed and patented a surface modification technology rooted in chemical mechanical planarization (CMP), a process used in advanced semiconductor chip manufacturing. Planatome’s innovative approach creates ultra-smooth, high-precision surgical blades that reduce tissue trauma and improve patient outcomes. With ongoing trials and positive feedback from surgeons, Planatome continues to explore new applications for its nano-polishing technology in both medical and non-medical markets.